TXG — 10X GENOMICS INC

Ownership history in EntryPoint Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in 10X GENOMICS INC (TXG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.28% (2025 Q2)
Avg. % of fund
0.14%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,472 -27,155 -57.0% 0.09% $239K $11.69
2025 Q2 REDUCED 47,627 -510 -1.1% 0.28% $552K $11.58
2025 Q1 ADDED 48,137 +47,265 +5420.3% 0.19% $420K $8.73
2024 Q2 REDUCED 872 -6,717 -88.5% 0.02% $17K $19.45
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TXG price (monthly, adj. close)

Other funds also holding TXG

As of 2025 Q4 — sorted by position size

Freshford Capital Management, LLC 3Y 7Y 5.45% Tao Capital Management LP 3Y 2.96% ARCH Venture Management, LLC 3Y 7Y 1.85% Quantedge Capital Pte Ltd 3Y 1.59% Sands Capital Alternatives, LLC 3Y 1.52% Casdin Capital, LLC 3Y 7Y 1.42% ARK Investment Management LLC 3Y 7Y 1.37% Exome Asset Management LLC 1.28% Amova Asset Management Americas, Inc. 3Y 7Y 1.03% CLOUGH CAPITAL PARTNERS L P 3Y 7Y 0.88%
← Back to EntryPoint Capital, LLC Holdings